參考文獻/References:
[1] 梁文娜,沈建英,閔莉.絕經后骨質疏松癥腎虛證與骨髓基質干細胞分化失衡內在聯系的探微[J].中華中醫(yī)藥雜志,2020,35(10):4794-4796.
[2] COSMAN F.Long-term treatment strategies for postmeno-pausal osteoporosis[J].Curr Opin Rheumatol,2018,30(4):420-426.
[3] YANG L,SATO M,SAITO-ABE M,et al.25-Hydroxyvitamin D levels among 2-year-old children:findings from the Japan environment and children's study(JECS)[J].BMC Pediatr,2021,21(1):539.
[4] RAJAKUMAR K,HOLICK M F,MOORE C G,et al.Impact of seasonal flux on 25-hydroxyvitamin D and bone turnover in pre-and early pubertal youth[J].Pediatr Int,2014,56(1):35-42.
[5] DOMÍNGUEZ-MENÉNDEZ G,POGGI H,MOORE R,et al.Seasonal variations in 25-hydroxy vitamin D3,parathormone and alkaline phosphatase in school-aged children[J].Rev Chil Pediatr,2020,91(6):881-890.
[6] LIN J,CHEN L,NI S,et al.Association between sleep quality and bone mineral density in Chinese women vary by age and menopausal status[J].Sleep Med,2019,53:75-80.
[7] ZHU Y,LIU S,CHEN W,et al.Epidemiology of low-energy fracture in Chinese postmenopausal women:changing trend of incidence since menopause and associated risk factors,a national population-based survey[J].Menopause,2019,26(3):286-292.
[8] WU Q Y,WANG J,TONG X,et al.Emerging role of circadian rhythm in bone remodeling[J].J Mol Med(Berl),2019,97(1):19-24.
[9] SWANSON C M,KOHRT W M,BUXTON O M,et al.The importance of the circadian system & sleep for bone health[J].Metabolism,2018,84:28-43.
[10] 李歡,徐尚福,劉杰.生物鐘基因:中藥作用的新靶點[J].中華中醫(yī)藥雜志,2017,32(12):5464-5467.
[11] HIRAI T,TANAKA K,TOGARI A.β-adrenergic receptor signaling regulates Ptgs2 by driving circadian gene expre-ssion in osteoblasts[J].J Cell Sci,2014,127(17):3711-3719.
[12] HIRAI T,TANAKA K,TOGARI A.α1B-Adrenergic receptor signaling controls circadian expression of Tnfrsf11b by regulating clock genes in osteoblasts[J].Biol Open,2015,4(11):1400-1409.
[13] HIRAI T,TANAKA K,TOGARI A.α1-adrenergic receptor signaling in osteoblasts regulates clock genes and bone morphogenetic protein 4 expression through up-regulation of the transcriptional factor nuclear factor IL-3(Nfil3)/E4 promoter-binding protein 4(E4BP4)[J].J Biol Chem,2014,289(24):17174-17183.
[14] SCHILPEROORT M,KROON J,KOOIJMAN S,et al.Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female mice[J].Aging Cell,2021,20(10):e13474.
[15] FUJIHARA Y,KONDO H,NOGUCHI T,et al.Glucocorticoids mediate circadian timing in peripheral osteoclasts resulting in the circadian expression rhythm of osteoclast-related genes[J].Bone,2014,61:1-9.
[16] HANYU R,HAYATA T,NAGAO M,et al.Per-1 is a speci-fic clock gene regulated by parathyroid hormone(PTH)signaling in osteoblasts and is functional for the transcriptional events induced by PTH[J].J Cell Biochem,2011,112(2):433-438.
[17] KUNIMOTO T,OKUBO N,MINAMI Y,et al.A PTH-responsive circadian clock operates in ex vivo mouse femur fracture healing site[J].Sci Rep,2016,6:22409.
[18] MUNMUN F,WITT-ENDERBY P A.Melatonin effects on bone:Implications for use as a therapy for managing bone loss[J].J Pineal Res,2021,71(1):e12749.
[19] MACDONALD I J,TSAI H C,CHANG A C,et al.Melatonin inhibits osteoclastogenesis and osteolytic bone metastasis:implications for osteoporosis[J].Int J Mol Sci,2021,22(17):9435.
[20] FU L,PATEL M S,BRADLEY A,et al.The molecular clock mediates leptin-regulated bone formation[J].Cell,2005,122(5):803-815.
[21] MARONDE E,SCHILLING A F,SEITZ S,et al.The clock genes period 2 and cryptochrome 2 differentially balance bone formation[J].PLoS One,2010,5(7):e11527.
[22] SAMSA W E,VASANJI A,MIDURA R J,et al.Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype[J].Bone,2016,84:194-203.
[23] MIN H Y,KIM K M,WEE G,et al.BMAL1 induces osteoblast differentiation via regulation of BMP2 expression in MC3T3-E1 cells[J].Life Sci,2016,162:41-46.
[24] XU C,OCHI H,FUKUDA T,et al.Circadian clock regulates bone resorption in mice[J].J Bone Miner Res,2016,31(7):1344-1355.
[25] DUDEK M,MENG Q J.Running on time:the role of circadian clocks in the musculoskeletal system[J].Biochem J,2014,463(1):1-8.
[26] GIBBS J E,BLAIKLEY J,BEESLEY S,et al.The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines[J].Proc Natl Acad Sci U S A,2012,109(2):582-587.
[27] KIM K,KIM J H,KIM I,et al.Rev-erbα negatively regulates osteoclast and osteoblast differentiation through p38 MAPK signaling pathway[J].Mol Cells,2020,43(1):34-47.
[28] TIAN Y,GONG Z,ZHAO R,et al.Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882/Rev-erbα axis in Raw264.7 cells[J].Int J Mol Med,2021,47(2):633-642.
[29] HE Y,LIN F,CHEN Y,et al.Overexpression of the circadian clock gene Rev-erbα affects murine bone mesenchymal stem cell proliferation and osteogenesis[J].Stem Cells Dev,2015,24(10):1194-1204.
[30] 胡巍,王譯凡,袁一方,等.節(jié)律基因調控成骨和破骨活動機制的研究進展[J].國際口腔醫(yī)學雜志,2019,46(3):302-307.
[31] MEYER T,KNEISSEL M,MARIANI J,et al.In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism[J].Proc Natl Acad Sci U S A,2000,97(16):9197-9202.
[32] KAWAI M,GREEN CB,LECKA-CZERNIK B,et al.A circadian-regulated gene,Nocturnin,promotes adipogenesis by stimulating PPAR-gamma nuclear translocation[J].Proc Natl Acad Sci U S A,2010,107(23):10508-10513.
[33] KAWAI M,ROSEN CJ.PPARγ:a circadian transcription factor in adipogenesis and osteogenesis[J].Nat Rev Endocrinol,2010,6(11):629-636.
[34] CHEN W,CHEN X,CHEN A C,et al.Melatonin restores the osteoporosis-impaired osteogenic potential of bone ma-rrow mesenchymal stem cells by preserving SIRT1-mediated intracellular antioxidant properties[J].Free Radic Biol Med,2020,146:92-106.
[35] TSUKAMOTO-YAMAUCHI N,TERASAKA T,IWASAKI Y,et al.Interaction of pituitary hormones and expression of clock genes modulated by bone morphogenetic protein-4 and melatonin[J].Biochem Biophys Res Commun,2015,459(1):172-177.
[36] XU J,LOMBARDI G,JIAO W,et al.Effects of exercise on bone status in female subjects,from young girls to post-menopausal women:an overview of systematic reviews and meta-analyses[J].Sports Med,2016,46(8):1165-1182.
[37] 李建軍,蔡榕琪,孟依臨,等.特定冬季服用補腎中藥對絕經后骨質疏松癥患者骨吸收影響的研究[J].世界中醫(yī)藥,2017,12(9):2109-2113.
[38] 蔡榕琪,孟依臨,畢晉,等.冬夏使用補腎中藥治療絕經后骨質疏松癥臨床研究[J].天津中醫(yī)藥大學學報,2019,38(2):139-142.
[39] MANIOS Y,MOSCHONIS G,LYRITIS G P.Seasonal variations of vitamin D status in Greek postmenopausal women receiving enriched dairy products for 30 months:the post-menopausal health study[J].Eur J Clin Nutr,2011,65(3):412-414.
[40] MICIC I,JEON I H,PARK S H,et al.The effect of short-term low-energy ultraviolet B irradiation on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis:a randomized single-blinded controlled clinical trial[J].Srp Arh Celok Lek,2013,141(9/10):615-622.
[41] 張改,陳玉梅,李淑芳,等.5117例股骨頸骨折患者流行病學調查分析[J].天津護理,2021,29(5):505-508.
[42] MAZZUCCHELLI R,CRESPÍ-VILLARÍAS N,PÉREZ-FERNÁNDEZ E,et al.Weather conditions and their effect on seasonality of incident osteoporotic hip fracture[J].Arch Osteoporos,2018,13(1):28.
[43] EASTELL R,DIJK D J,SMALL M,et al.Morning vs evening dosing of the cathepsin K inhibitor ONO-5334:effects on bone resorption in postmenopausal women in a rando-mized,phase 1 trial[J].Osteoporos Int,2016,27(1):309-318.
[44] LUCHAVOVA M,ZIKAN V,MICHALSKA D,et al.The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis[J].Eur J Endocrinol,2011,164(4):643-648.
[45] ANDO H,OTODA T,OOKAMI H,et al.Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis[J].Clin Exp Pharmacol Physiol,2013,40(3):227-232.
[46] FU X,ZHAO X,LU H,et al.Association between sleep duration and bone mineral density in Chinese women[J].Bone,2011,49(5):1062-1066.
[47] LIN J,CHEN L,NI S,et al.Association between sleep qua-lity and bone mineral density in Chinese women vary by age and menopausal status[J].Sleep Med,2019,53:75-80.
[48] SCHILPEROORT M,BRAVENBOER N,LIM J,et al.Circadian disruption by shifting the light-dark cycle negatively affects bone health in mice[J].FASEB J,2020,34(1):1052-1064.
[49] REN B,MA C,CHEN L,et al.Impact of time-restricted feeding to late night on adaptation to a 6 h phase advance of the light-dark cycle in mice[J].Front Physiol,2021,12:634187.
(收稿日期:2022-07-14 本文編輯:呂寧)
相似文獻/References:
[1]李林軍.應用膨脹式椎弓根螺釘內固定治療合并骨質疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):12.
[3]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統
在老年腰椎疾患手術中的應用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經后骨質疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經后骨質疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(02):19.
[6]項旻,楊虹,林愛菊,等.絕經后2型糖尿病患者骨質疏松與血微量元素的關系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(02):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術和基質輔助激光解吸電離飛行時間質譜技術在原發(fā)性Ⅰ型骨質疏松癥血清標志蛋白篩選中的應用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經后骨質疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內脂素水平與絕經后骨質疏松癥的
相關性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(02):16.
[10]許超,肖魯偉,吳承亮.絕經后女性骨質疏松癥辨證分型與抑郁焦慮的關系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(02):3.
[11]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):7.
[12]歐國峰,劉鑫,董博,等.絕經后骨質疏松癥的免疫學研究進展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經后骨質疏松癥腎虛證的關系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經后骨質疏松大鼠骨代謝紊亂的作用機制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):1.
[16]劉晨,李興勇,姚興璋,等.絕經后骨質疏松癥的流行病學概況及發(fā)病機制研究進展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經后骨質疏松癥發(fā)生發(fā)展過程中細胞自噬的機制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯合阿侖膦酸鈉口服治療絕經后骨質疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(02):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經后骨質疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(02):11.
[20]趙凡,劉全,吳連國.口服強骨飲聯合碳酸鈣D3片治療絕經后骨質疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(02):26.